Catalpa Tree Allergy: An Insect-Pollinated Tree With Anti-Inflammatory Chemistry

Catalpa pollen is not a recognized cause of seasonal allergies. The tree is insect-pollinated — its large, bell-shaped flowers attract bees and hummingbirds, and its pollen is heavy and not designed for wind transport. No WHO/IUIS pollen allergens have been characterized for any Catalpa species, and no clinical studies document catalpa as a significant aeroallergen. Patients who experience sneezing, congestion, and itchy eyes during catalpa bloom in late May through June are reacting to concurrent grass pollens, which peak at the exact same time and are among the most potent aeroallergens in North America.

Catalpol is an iridoid glycoside — the signature biochemical compound produced by catalpa trees. Far from being an allergen, catalpol has been extensively studied for its anti-inflammatory, neuroprotective, and antioxidant properties. Preclinical research has investigated catalpol as a potential therapeutic agent for inflammatory conditions, diabetes, and neurodegeneration. No published evidence suggests catalpol causes allergic sensitization or immune-mediated reactions in humans. The compound is found in the bark, leaves, and seed pods of catalpa trees and represents one of the plant kingdom's anti-inflammatory molecules rather than a pro-allergenic one.

Sneezing near catalpa trees in late May through June is caused by concurrent grass pollen exposure, not by catalpa. Grass pollens — timothy, Kentucky bluegrass, ryegrass, bermuda — reach their annual peak precisely when catalpa blooms. These grasses produce enormous quantities of lightweight pollen that travels for miles on wind currents and is invisible to the naked eye. The catalpa's showy white flowers, by contrast, are highly visible and attract attention, making them an easy but incorrect scapegoat. An allergy test for grass pollens will confirm the actual sensitization driving your sneezing episodes.

No allergic reactions to catalpa seed pods have been documented in the medical literature. The distinctive long pods — often 30 to 50 centimeters in length, giving the tree its cigar tree nickname — contain flat-winged seeds without documented irritant or allergenic properties. Handling the pods does not cause contact dermatitis, and no case reports of skin or respiratory reactions from pod material exist. The pods persist on the tree through winter and litter the ground in spring, which may create a messy appearance but poses no allergy hazard. Children who play with the pods are not at risk of allergic sensitization.

Removing catalpa trees will not reduce your allergy symptoms because catalpa is not contributing to your airborne pollen exposure. The tree is insect-pollinated and produces negligible airborne pollen. If you have seasonal allergies during the catalpa bloom window, the responsible allergens are grass and late tree pollens that saturate the air regardless of whether catalpa is present in your yard. A comprehensive pollen allergy test will identify the actual triggers, and treatments including immunotherapy can provide lasting symptom relief without the expense and environmental cost of removing a healthy shade tree.

Catalpa belongs to Bignoniaceae, a family that has no established cross-reactivity networks with any major allergenic tree family. It is not part of Fagales (birch, oak, alder, hazel, hornbeam — the PR-10/Bet v 1 cross-reactivity network), not part of Cupressaceae (cedar, cypress, juniper), not part of Oleaceae (olive, ash, privet), and not part of Pinaceae (pine, spruce, larch). This taxonomic isolation means catalpa does not participate in any of the well-characterized pollen cross-reactivity syndromes that drive clinical allergy. The Bignoniaceae family includes trumpet vine and jacaranda, none of which are significant aeroallergens.

The simplest clinical test is observational: note whether your symptoms persist after catalpa flowers have fallen in late June. Grass pollen season typically extends through July in most eastern US regions, so if symptoms continue well past catalpa bloom, grass pollen is confirmed as the driver. For definitive diagnosis, a grass pollen allergy test (skin prick or specific IgE blood test) identifies whether you carry IgE antibodies to grass pollen proteins. Correlating your daily symptom diary with National Allergy Bureau grass pollen counts provides additional evidence. No catalpa-specific allergy test exists because no characterized allergens have been identified.

No food cross-reactivity has been documented for catalpa. Bignoniaceae is not part of the Fagales order that drives oral allergy syndrome between birch-family pollens and Rosaceae fruits (apple, peach, cherry), nor is it part of any other family with established pollen-food cross-reactivity networks. If you experience oral tingling or lip swelling when eating raw fruits during the catalpa bloom window, the likely explanation is grass pollen-driven profilin cross-reactivity or concurrent birch pollen sensitization driving PR-10-mediated oral allergy syndrome — not catalpa. An allergist can clarify the mechanism through component-resolved diagnostics.

Catalpa trees pose no documented asthma risk. No published evidence connects catalpa pollen to asthma exacerbations, and the tree's insect-pollinated biology makes it an implausible bronchial trigger. Patients with asthma who experience worsening symptoms during catalpa bloom in late May through June should consider grass pollen as the trigger — grass pollen is one of the most potent asthma-exacerbating aeroallergens and peaks at exactly the same time. Asthma action plans should focus on grass pollen count monitoring and pre-season controller medication adjustments rather than proximity to catalpa trees.

Developing a specific immune-mediated allergy to catalpa pollen is not a recognized clinical possibility because no pollen allergens have been characterized for this insect-pollinated tree. However, adult-onset sensitization to the grass and tree pollens that peak during catalpa bloom season is well documented. Adults who relocate to areas with different grass species or higher grass pollen concentrations may develop new sensitization that manifests during the same late-spring window when catalpa flowers. This is new grass pollen allergy, not catalpa allergy, and it responds well to standard immunotherapy targeting the confirmed grass pollen sensitizations.